This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medbox Signs Ad Deal With Entrepreneur Magazine





HOLLYWOOD, Calif., March 8, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) ( www.medboxinc.com), announced they have signed a deal with Entrepreneur Media for a full page ad placement in their award winning magazine "Entrepreneur." This leading small business magazine serves 619,988 paid subscribers as of July 2012 and boasts a total readership exceeding 2.7 million. The placement represents Medbox's most aggressive marketing project to date. The ad, which will debut in the May issue and will continue for at least a six month run, will urge Entrepreneur's ambitious and affluent audience to "Join The Green Rush."



"This marks the first time any marijuana related business, albeit a passive relation as is the case with Medbox, will be featured in a mainstream investment periodical of this magnitude," said Dr. Bruce Bedrick, CEO of Medbox, Inc. "The advertisement is the most significant promotion vehicle the company has ever pursued and we are elated that Entrepreneur is fostering a working relationship with Medbox."



The company also issued a shareholder update via email to its certificate holders of record. Pursuant to regulations, the company is making the information contained in the email public via press release. The email contained the following highlights achieved by the company over the last few months:

  • Highest revenue generating month in the company's history occurring in January of 2013 at $900,000
  • Commenced audit of prior 2-years financials in order to become fully reporting with the SEC (target completion this month)
  • Confirmed a total of over $4.5m revenue booked for the 2012 calendar year
  • Acquired an interest in Bio-Tech Medical Software, Inc. (business has 2 patents that are instrumental in stopping prescription pill abuse through the use of biometric technology at pharmacies)
  • Commenced acquisition discussions with 4 additional targets in related businesses to Medbox
  • Recorded first balance sheet with over $1 million in cash reserve on hand
  • Recorded 34% EBITDA margin in 2012 financials
  • Appeared live on Fox Business Channel, Bloomberg, Huffington Post Live, and CNBC
  • Commenced building up to 30 dispensaries in San Diego for new and existing consulting clients
  • Began consulting and technology sales in Massachusetts, Connecticut, Colorado, and Washington regarding new canna-business setups.
  • Secured a $6 million equity transaction with a private investment company ( $1 million paid to date and another $5 million to be paid by May 2013).
  • Founder and majority shareholder, Vincent Mehdizadeh, caused a board resolution to be signed allowing for 612,000 in common shares and a 3,000,000 preferred shares to be placed back to treasury for the company. These shares, which were in Mr. Mehdizadeh's possession, were given back to the company and cancelled to assist with acquisition activity without diluting existing shareholders.




1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,386.50 -292.20 -1.65%
S&P 500 2,042.99 -14.10 -0.69%
NASDAQ 4,698.2940 -73.4690 -1.54%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs